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Sir,
A synthesis of available prospective epidemiological studies indi-
cates that chronic infection with Helicobacter pylori is about two
or three times as common in people with gastric cancer than in
others (risk ratio 2.5, 95% confidence interval 1.9–3.4) (Danesh,
1999a). As stated previously (Danesh, 1999b), some potential
biases in published studies may have exaggerated this estimate
(such as the preferential publication of more striking findings
and/or inadequate adjustment for possible confounders, e.g.,
smoking); by contrast, other possible biases may have resulted in
some underestimation (such as the use of serological assays in
developing countries based on bacterial antigens found in devel-
oped countries and/or failure of studies to exclude from analyses
the first few years of follow-up to minimize any effects of early
gastric cancer on H. pylori serostatus) (Danesh, 1999b). Such
factors cannot, however, plausibly account for much of the overall
association observed between H. pylori infection and gastric
cancer (although more appropriate allowances for such biases in
future studies might somewhat change the present estimate of the
magnitude of risk).
Ponce-de-Leon and colleagues discuss another possible bias
that might overestimate the association between H. pylori infec-
tion and gastric cancer. They suggest that, in comparison with non-
infected people, H. pylori seropositive individuals might receive
additional gastroenterological investigation (such as upper
gastrointestinal endoscopy) due to increased dyspeptic symptoms,
thereby resulting in earlier and more frequent diagnosis of gastric
cancer. Any such effect, however, is unlikely to be important, as
there is no good evidence of any strong association of H. pylori
infection with non-ulcer dyspepsia or with other common causes
of dyspepsia in the general population, apart from peptic ulcera-
tion (Danesh et al, 2000). Moreover, the claim of Ponce-de-Leon
and colleagues that there is a higher prevalence of H. pylori infec-
tion in early gastric cancer than in more advanced disease is of
uncertain validity (as their study was based on fewer than 50 non-
invasive tumours), and the authors themselves state that there were
no significant associations in their study between H. pylori status
and the interval between symptoms and the diagnosis of cancer.
J Danesh, Clinical Trial Service Unit and Epidemiological Studies
Unit, University of Oxford, Radcliffe Infirmary, Oxford OX2 6HE,
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